Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Clinical Science at South Bristol

University of Bristol

Level 7 CSSB

Bristol Royal Infirmary

Name/email consistency: high

Clinical Science at South Bristol, University of Bristol, Level 7 CSSB, Bristol Royal Infirmary, UK. 2009
University of Bristol, Bristol, UK. 2008
Department of Medicine, Bristol Royal Infirmary, Bristol, UK. 2004
University Division of Medicine, Bristol Royal Infirmary, Marlborough Street, Bristol BS2 8HW, UK. 2003
Gastroenterology Division, Brigham and Women's Hospital, Harvard Medical School, Boston, USA. 2001

Volatile organic compounds as diagnostic biomarkers in gastrointestinal and liver diseases. Probert, C.S., Ahmed, I., Khalid, T., Johnson, E., Smith, S., Ratcliffe, N. J. Gastrointestin. Liver. Dis (2009) [Pubmed]
Is once-daily dosing of mesalazine effective for maintenance of remission in patients with ulcerative colitis? Probert, C.S. Nat. Clin. Pract. Gastroenterol. Hepatol (2008) [Pubmed]
A novel method for rapidly diagnosing the causes of diarrhoea. Probert, C.S., Jones, P.R., Ratcliffe, N.M. Gut (2004) [Pubmed]
Infliximab in moderately severe glucocorticoid resistant ulcerative colitis: a randomised controlled trial. Probert, C.S., Hearing, S.D., Schreiber, S., Kühbacher, T., Ghosh, S., Arnott, I.D., Forbes, A. Gut (2003) [Pubmed]
Prevalence of an ulcerative colitis-associated CD8+ T cell receptor beta-chain CDR3-region motif and its association with disease activity. Probert, C.S., Chott, A., Saubermann, L.J., Stevens, A.C., Balk, S.P., Blumberg, R.S. J. Clin. Immunol. (2001) [Pubmed]